NASDAQ:SSKN STRATA Skin Sciences (SSKN) Stock Price, News & Analysis → Was the Great Financial Crisis fun? (From Brooks Enterprises) (Ad) Free SSKN Stock Alerts $0.38 -0.01 (-3.71%) (As of 03:57 PM ET) Add Compare Share Share Today's Range$0.36▼$0.3850-Day Range$0.37▼$0.5652-Week Range$0.26▼$1.08Volume21,652 shsAverage Volume31,818 shsMarket Capitalization$13.37 millionP/E RatioN/ADividend YieldN/APrice Target$3.80 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get STRATA Skin Sciences alerts: Email Address STRATA Skin Sciences MarketRank™ Stock AnalysisAnalyst Rating0.00 Rating ScoreUpside/Downside900.0% Upside$3.80 Price TargetShort InterestHealthy0.42% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.27) to ($0.13) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.84 out of 5 starsMedical Sector821st out of 927 stocksSurgical & Medical Instruments Industry93rd out of 100 stocks 2.0 Analyst's Opinion Amount of Analyst CoverageSTRATA Skin Sciences has received no research coverage in the past 90 days.Read more about STRATA Skin Sciences' stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.42% of the float of STRATA Skin Sciences has been sold short.Short Interest Ratio / Days to CoverSTRATA Skin Sciences has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in STRATA Skin Sciences has recently increased by 175.00%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldSTRATA Skin Sciences does not currently pay a dividend.Dividend GrowthSTRATA Skin Sciences does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SSKN. Previous Next 2.4 News and Social Media Coverage News SentimentSTRATA Skin Sciences has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for STRATA Skin Sciences this week, compared to 1 article on an average week.Search Interest1 people have searched for SSKN on MarketBeat in the last 30 days. MarketBeat Follows1 people have added STRATA Skin Sciences to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, STRATA Skin Sciences insiders have not sold or bought any company stock.Percentage Held by Insiders40.43% of the stock of STRATA Skin Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 32.43% of the stock of STRATA Skin Sciences is held by institutions.Read more about STRATA Skin Sciences' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for STRATA Skin Sciences are expected to grow in the coming year, from ($0.27) to ($0.13) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of STRATA Skin Sciences is -1.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of STRATA Skin Sciences is -1.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSTRATA Skin Sciences has a P/B Ratio of 1.03. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about STRATA Skin Sciences' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Brooks EnterprisesWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, was terrible! The majority of market indexes lost over 50% of their value. Almost every day, traders would look at their trading accounts and just see a sea of red.Get those kind of results during the Great Financial Crisis, without having to study more About STRATA Skin Sciences Stock (NASDAQ:SSKN)STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.Read More SSKN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SSKN Stock News HeadlinesJune 4 at 8:00 AM | globenewswire.comSTRATA Skin Sciences to Participate in June Dermatology ConferencesMay 22, 2024 | wsj.comStrata Skin Sciences Inc.May 16, 2024 | finanznachrichten.deSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate UpdateMay 16, 2024 | finance.yahoo.comQ1 2024 STRATA Skin Sciences Inc Earnings CallMay 16, 2024 | insidermonkey.comSTRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q1 2024 Earnings Call TranscriptMay 16, 2024 | msn.comSTRATA Skin Sciences Sees Encouraging Signs Amid Strategic Shift, Despite Revenue DipMay 16, 2024 | finance.yahoo.comStrata Skin Sciences Inc (SSKN) Q1 2024 Earnings Call Transcript Highlights: Navigating ...May 15, 2024 | msn.comSTRATA Skin Sciences Achieves Milestone with Over 100 TheraClear®X Devices InstalledMay 15, 2024 | globenewswire.comSTRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate UpdateMay 15, 2024 | msn.comSTRATA Skin Sciences to Attend Benchmark Healthcare Investor ConferenceMay 14, 2024 | markets.businessinsider.comStrata Skin Sciences earnings preview: what to expectMay 14, 2024 | msn.comSTRATA Skin Sciences Q1 2024 Earnings PreviewMay 14, 2024 | globenewswire.comSTRATA Skin Sciences Surpasses 100 Domestic Installations of TheraClear®X Devices as of March 31, 2024May 13, 2024 | globenewswire.comSTRATA Skin Sciences to Participate in the Benchmark Healthcare House Call Virtual 1x1 Investor ConferenceMay 11, 2024 | msn.comSTRATA Skin Sciences to Announce Q1 2024 Financial Results, Hosts Conference CallMay 8, 2024 | finance.yahoo.comSTRATA Skin Sciences to Report First Quarter 2024 Financial Results on May 15, 2024 and Provide Corporate UpdateMay 5, 2024 | fool.comStrata Skin Sciences (NASDAQ: SSKN)April 30, 2024 | globenewswire.comSTRATA Skin Sciences Announces XTRAC® Comeback Placements in the First Quarter of 2024April 28, 2024 | msn.comSTRATA Skin Sciences Announces Reverse Stock Split to Meet Nasdaq’s Minimum Bid Price RequirementApril 27, 2024 | finanznachrichten.deSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces 1-for-10 Reverse Stock SplitApril 26, 2024 | marketwatch.comStrata Skin Sciences to Effect a 1-for-10 Reverse Stock SplitApril 26, 2024 | globenewswire.comSTRATA Skin Sciences Announces 1-for-10 Reverse Stock SplitApril 23, 2024 | globenewswire.comSTRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024April 18, 2024 | msn.comSTRATA Skin Sciences (SSKN) Price Target Increased by 32.61% to 3.11April 10, 2024 | msn.comSTRATA Skin Sciences Bolsters International Presence with Renewed Distribution Agreements in AsiaSee More Headlines Receive SSKN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STRATA Skin Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Today6/04/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:SSKN CUSIPN/A CIK1051514 Webwww.strataskinsciences.com Phone(215) 619-3200Fax215-619-3208Employees99Year FoundedN/APrice Target and Rating Average Stock Price Target$3.80 High Stock Price Target$3.80 Low Stock Price Target$3.80 Potential Upside/Downside+923.7%Consensus Rating Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)($0.33) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,830,000.00 Net Margins-34.92% Pretax Margin-35.20% Return on Equity-65.76% Return on Assets-19.69% Debt Debt-to-Equity Ratio1.60 Current Ratio1.05 Quick Ratio0.84 Sales & Book Value Annual Sales$33.36 million Price / Sales0.39 Cash FlowN/A Price / Cash FlowN/A Book Value$0.37 per share Price / Book1.00Miscellaneous Outstanding Shares35,060,000Free Float20,886,000Market Cap$13.01 million OptionableNot Optionable Beta1.48 Social Links Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. Dolev Rafaeli Ph.D. (Age 60)President, CEO & Vice-Chairman Comp: $408.71kMr. Christopher Lesovitz (Age 41)Chief Financial Officer Comp: $493.19kMr. Shmuel Gov (Age 64)Chief Operating Officer Comp: $490.44kMr. Jay Sturm (Age 68)General Counsel & Corporate Secretary Mr. Michael R. Stewart (Age 67)Independent Consultant Comp: $732.9kKey CompetitorsApyx MedicalNASDAQ:APYXSEP AcquisitionNASDAQ:SEPACarmellNASDAQ:CTCXLENSARNASDAQ:LNSRHoldco Nuvo Group D.GNASDAQ:NUVOView All CompetitorsInsiders & InstitutionsAzzad Asset Management Inc. ADVBought 49,800 shares on 4/19/2024Ownership: 0.191%Shmuel GovBought 20,000 shares on 12/1/2023Total: $9,000.00 ($0.45/share)Samuel RubinsteinSold 1,000 sharesTotal: $320.00 ($0.32/share)Robert Joseph MocciaBought 42,000 shares on 8/10/2023Total: $28,140.00 ($0.67/share)Christopher LesovitzBought 15,151 shares on 8/10/2023Total: $10,151.17 ($0.67/share)View All Insider TransactionsView All Institutional Transactions SSKN Stock Analysis - Frequently Asked Questions What is STRATA Skin Sciences' stock price target for 2024? 0 brokerages have issued 12 month price objectives for STRATA Skin Sciences' stock. Their SSKN share price targets range from $3.80 to $3.80. On average, they predict the company's share price to reach $3.80 in the next twelve months. This suggests a possible upside of 900.0% from the stock's current price. View analysts price targets for SSKN or view top-rated stocks among Wall Street analysts. How have SSKN shares performed in 2024? STRATA Skin Sciences' stock was trading at $0.5501 on January 1st, 2024. Since then, SSKN shares have decreased by 30.9% and is now trading at $0.38. View the best growth stocks for 2024 here. Are investors shorting STRATA Skin Sciences? STRATA Skin Sciences saw a increase in short interest in May. As of May 15th, there was short interest totaling 77,000 shares, an increase of 175.0% from the April 30th total of 28,000 shares. Based on an average daily trading volume, of 30,100 shares, the days-to-cover ratio is currently 2.6 days. Currently, 0.4% of the company's stock are short sold. View STRATA Skin Sciences' Short Interest. When is STRATA Skin Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our SSKN earnings forecast. How were STRATA Skin Sciences' earnings last quarter? STRATA Skin Sciences, Inc. (NASDAQ:SSKN) issued its quarterly earnings data on Wednesday, May, 15th. The medical device company reported ($0.10) earnings per share for the quarter. The medical device company earned $6.75 million during the quarter. STRATA Skin Sciences had a negative trailing twelve-month return on equity of 65.76% and a negative net margin of 34.92%. When did STRATA Skin Sciences' stock split? Shares of STRATA Skin Sciences reverse split on Friday, June 7th 2024. The 1-10 reverse split was announced on Friday, June 7th 2024. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, June 7th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of STRATA Skin Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other STRATA Skin Sciences investors own include Trevena (TRVN), Amarin (AMRN), Biocept (BIOC), Kopin (KOPN), OPKO Health (OPK), Plug Power (PLUG), AbbVie (ABBV), SCYNEXIS (SCYX), Tonix Pharmaceuticals (TNXP) and Agile Therapeutics (AGRX). Who are STRATA Skin Sciences' major shareholders? STRATA Skin Sciences' stock is owned by many different institutional and retail investors. Top institutional investors include Azzad Asset Management Inc. ADV (0.19%). Insiders that own company stock include Christopher Lesovitz, Robert Joseph Moccia, Samuel Rubinstein, Shmuel Gov and William D Humphries. View institutional ownership trends. How do I buy shares of STRATA Skin Sciences? Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SSKN) was last updated on 6/4/2024 by MarketBeat.com Staff From Our PartnersNext President (Not Trump. Not Biden.)The Freeport SocietyElon Musk’s Final Masterpiece: “X-9840”Paradigm PressWho are Nvidia’s Silent Partners?Weiss RatingsWas the Great Financial Crisis fun?Brooks EnterprisesEverything from semiconductors to space shuttles depend on this overlooked mineralCapital TrendsCollapse of the Petrodollar Colonial MetalsAI's Next Magnificent SevenThe Oxford Club[Webinar] Understanding Covered CallsOIC Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STRATA Skin Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
